FGFR2 and intrahepatic cholangiocarcinoma: Furthermore, proliferation analysis showed that FGFR2 fusion+ ICC cells had increased sensitivity to RELA ablation or TPCA-1 treatment compared to a set of non-FGFR-driven ICC cell lines (Supplementary Fig. 6e, f).